Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Treatment Strategies and Novel Therapies
Anoushka Shenoy, Aijaz Ahmed, Donghee Kim · 2026
Read Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Treatment Strategies and Novel Therapies by Anoushka Shenoy, Aijaz Ahmed, Donghee Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575885.txt.
Description
Fatty liver disease tied to poor metabolic health now affects about a third of the world's people. Anoushka Shenoy and co-authors wrote this 2026 review of how the condition, called MASLD, is treated today. The review covers care for the liver damage that can follow, including scarring of the liver.
Lifestyle change, such as better diet and more exercise, stays the base of care, the authors explain. They then survey the new drugs, noting two recent approvals for the inflamed, scarred form of the disease. Other drugs in late-stage trials work in varied ways, and the review weighs each one. Readers get a clear map of current care and of the treatments now on the way.
Catalog record
| CREATOR | Anoushka Shenoy, Aijaz Ahmed, Donghee Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |